Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
about
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.Integrin β1 regulates leiomyoma cytoskeletal integrity and growth.Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver diseaseClinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.Transient Elastography for the Detection of Liver Damage in Patients with HIVProteomics and liver fibrosis: identifying markers of fibrogenesis.Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.Molecular serum markers of liver fibrosis.Preoperative liver function assessments to estimate the prognosis and safety of liver resections.Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis.Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease.Adverse outcome pathway development from protein alkylation to liver fibrosis.Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer.Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma.Is herbal medicine effective in the management of patients with chronic hepatitis C?Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis C.Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-Beta 1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.
P2860
Q33397092-9D12DD0B-4ACC-43F3-A189-90593472F61DQ34084035-3AC2DFED-0C87-4D96-BF81-746EB23F8C5EQ34630224-8AB0D496-C642-43F1-A8B0-8B24E5539020Q35958287-2CDA5776-504D-4313-A319-38D16607427DQ36073396-8E89B416-6268-4D42-A16E-E6BFDD7E2463Q37579910-1BE11DFC-1012-4EB5-A781-3C704A3B1D8FQ37856310-9F23BFD0-0EC0-4AE0-9F65-850050B90521Q38032835-ECDC751B-DF51-4B0D-99B3-9C2A491025D8Q38087845-ADD24E5B-00CD-472C-BCA3-76342B7BB10FQ38366999-F44E58D1-2407-44F5-8106-906508CC0F9DQ38504104-BD1AADEC-5399-4153-AF6B-11A4D4E7BF25Q38932043-9FB3625A-4470-4B29-96A5-7D146884C54DQ39726007-E14B7968-554B-4727-9292-548108CD36EAQ40054478-F100CF84-3A24-43C4-84A0-2837B74E88C5Q40565218-272D525A-F4C4-4110-9F90-E8F1231AF020Q43007383-92D35D5D-921B-41AD-8745-561FE5B80E2FQ47122280-6742C7FD-2F14-4E55-9F86-9F07F4ABCB14Q50198283-2B0FCB69-0339-45E3-A6B3-5352373EE48FQ52732629-60FF7B17-6CF8-49AF-B821-BC09F59F4881
P2860
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@en
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@nl
type
label
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@en
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@nl
prefLabel
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@en
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@nl
P2093
P2860
P356
P1476
Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.
@en
P2093
Axel-M Gressner
Chun-Fang Gao
Olav-A Gressner
P2860
P304
P356
10.3748/WJG.15.2433
P407
P577
2009-05-01T00:00:00Z